Biopharma Events

DACH: Where the world comes to understand what cannot be taught - how a culture of perfection becomes a measurable business advantage.

The €1 Billion Opportunity: Scaling the Future of Cure

DISCOVERY · INNOVATION · SCALE · From breakthrough science to commercial reality. DACH’s focused end-to-end forum for oligonucleotides and peptides, bringing together the region’s leaders to advance precision therapeutics.

The 5th ANZ Biologics Festival 2027 unites biopharma leaders to advance Australia & New Zealand's biologics industry through innovation partnerships and manufacturing expansion.

Engineering next-generation antibodies. Accelerating ADCs.

Europe’s leading end-to-end forum for oligonucleotides and peptides, bringing together 200+ leaders in Dublin to advance these modalities from Discovery and Innovation through to Scale and Commercialisation.

With major policy shifts, AI integration, and CDMO growth, Ireland stands at a crossroads; this summit defines what comes next.

The 17th Annual Vaccine World Summit unites global stakeholders to advance vaccine development and distribution, emphasizing India's production capacity and developing nations' access.

The 11th Biologics Festival India 2027 is a major life sciences conference focused on advancing vaccine and biologics development for emerging markets.

Biopharma APAC Confex is Asia-Pacific’s most comprehensive decision-maker-only biopharma conference and exhibition, bringing together 2,000+ attendees and 700+ companies across six co-located specialist conferences.

The region’s premier knowledge-sharing platform, featuring success stories from Asian biopharmas and expert insights from global biomanufacturing leaders on the latest innovations, process optimization, and regulatory advancements.

Join biopharma supply chain leaders to explore supply chain solutions, cold chain innovations and more. Features keynotes, panels, and networking.

Join Clinical Trials Festival Asia 2027, connecting industry leaders to explore innovations in clinical research across Asia.

The ADC Asia Congress 2027 will gather 300+ industry leaders in Singapore to explore the latest innovations in ADC development.

#CGTAsia2027: driving breakthroughs in research, clinical applications, and manufacturing, while addressing Asia’s unique challenges.

Join the Oligos & Peptides World Asia 2027, where industry leaders from biopharma and big pharma converge to foster collaboration, breakthrough therapies, and scalable manufacturing in Asia’s rapidly growing oligonucleotide, RNA and peptide sector.

The leading Nordic summit for biologics, biosimilars, and CGT, connecting R&D, clinical, and manufacturing leaders to drive regional innovation.

Biologics World Taiwan 2027 is the leading platform where over 300 global and local experts converge to shape the future of biologics, spanning Manufacturing, R&D, and Clinical Trials for biologic drugs, vaccines and Cell and Gene Therapies.

Biologics Manufacturing Korea 2027 unites global leaders to showcase breakthroughs in AI, automation, biosimilars, and supply chain excellence. Join us to shape the future of biotech in Asia’s powerhouse market.

#ADCBio2027 dives into next-gen ADC development, bridging innovation with clinical and commercial success.

Bringing together top minds from South Korea, Japan, China, and Taiwan, #CGTEA2027 drives breakthroughs in regenerative medicine, gene editing, and personalised therapies—fueling collaboration across biopharma, academia, and CDMOs.

Biopharma Korea Confex is Korea’s most comprehensive decision-maker-only biopharma conference and exhibition, bringing together 800+ attendees and 180+ companies across three co-located specialist conferences.

DACH: where a culture of perfection meets AI, policy change and supply chain pressure to become a measurable business advantage.

Where regulatory pioneers, operations leaders, digital quality architects, and manufacturing strategists come together to accelerate biologics manufacturing innovation; from flexible regulatory sandboxes to digital quality frameworks and future workforce strategies.